<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02885194</url>
  </required_header>
  <id_info>
    <org_study_id>2014.866</org_study_id>
    <nct_id>NCT02885194</nct_id>
  </id_info>
  <brief_title>Impact of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease</brief_title>
  <official_title>Impact of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease : Clinical and Neurophysiological Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain is a common symptom of Parkinson's disease (PD) but the physiology remains poorly&#xD;
      understood. Recent work suggests that subthalamic nucleus deep brain stimulation (STN-DBS)&#xD;
      could make a profit on the pain in PD.&#xD;
&#xD;
      The investigator would drive a study with a follow up of PD patients before and after&#xD;
      STN-DBS. The pain will be clinically explored by targeted questionnaires and&#xD;
      electrophysiological through laser evoked potentials.&#xD;
&#xD;
      The questionnaires are designed to quantify and characterize the pain in these patients.&#xD;
      Laser evoked potentials will, through repetitive stimulation, study both the functional&#xD;
      status of the afferent nociceptive pathways, their habituation to repetitive nociceptive&#xD;
      stimuli, and so better understand any abnormalities of the central processing of nociceptive&#xD;
      information.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modification of habituation in percentage, between tests performed before and after DBS</measure>
    <time_frame>After the second laser evoked potential which occurred around 3 months after STN-DBS</time_frame>
    <description>The habituation is the change of amplitude between the first and the second response of the double stimulation during the laser evoked potential. We calculated a percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in latency of laser evoked potential responses before and after DBS</measure>
    <time_frame>After the second laser evoked potential which occurred around 3 months after STN-DBS</time_frame>
    <description>latency is calculated in millisecond</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in amplitude of laser evoked potential responses before and after DBS</measure>
    <time_frame>After the second laser evoked potential which occurred around 3 months after STN-DBS</time_frame>
    <description>amplitude is calculated in microvolts</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Patients who underwent Deep Brain Stimulation (DBS)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who underwent Subthalamic Nucleus (STN)-DBS at Lyon</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laser-Evoked potential</intervention_name>
    <description>Laser-Evoked potential can document lesions of spinothalamic tract and lateral brainstem and of thalamo-cortical projections conducting nociceptive signals. The rapid heating of skin by infrared laser pulses stimulate small fibers sensory pathways. The main cortical laser evoked potential is a complex of components N2-P2. Evaluation of the registered potentials includes shape, latency and amplitude.</description>
    <arm_group_label>Patients who underwent Deep Brain Stimulation (DBS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A patient with idiopathic Parkinson's disease&#xD;
&#xD;
          -  Age between 30 and 70 inclusive.&#xD;
&#xD;
          -  No cognitive decline (MMS greater than or equal to 24)&#xD;
&#xD;
          -  Normal brain MRI&#xD;
&#xD;
          -  Informed consent signed&#xD;
&#xD;
          -  With or without pain sensation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of other neurological pathology that could explain the pain.&#xD;
&#xD;
          -  MMS less than 24&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphane THOBOIS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Neurologie C, Hôpital Neurologique, HCL</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>August 26, 2016</study_first_submitted>
  <study_first_submitted_qc>August 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2016</study_first_posted>
  <last_update_submitted>October 12, 2016</last_update_submitted>
  <last_update_submitted_qc>October 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson Disease</keyword>
  <keyword>Pain</keyword>
  <keyword>Deep Brain Stimulation</keyword>
  <keyword>Laser-Evoked Potentials</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

